Getinge AB Share Price

Equities

GETI B

SE0000202624

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 05:00:59 18/07/2024 pm IST 5-day change 1st Jan Change
214.4 SEK +14.47% Intraday chart for Getinge AB +13.63% -4.46%

Financials

Sales 2024 * 33.87B 3.21B 269B Sales 2025 * 35.37B 3.35B 280B Capitalization 51.01B 4.84B 404B
Net income 2024 * 2.65B 252M 21.04B Net income 2025 * 3.11B 295M 24.68B EV / Sales 2024 * 1.69 x
Net Debt 2024 * 6.33B 601M 50.2B Net Debt 2025 * 4.43B 420M 35.08B EV / Sales 2025 * 1.57 x
P/E ratio 2024 *
19.5 x
P/E ratio 2025 *
16.5 x
Employees 11,862
Yield 2024 *
2.44%
Yield 2025 *
2.73%
Free-Float 79.05%
More Fundamentals * Assessed data
Dynamic Chart
1 day+14.42%
1 week+13.63%
Current month+19.02%
1 month+20.77%
3 months+2.10%
6 months-2.24%
Current year-4.46%
More quotes
1 week
183.10
Extreme 183.1
214.80
1 month
174.85
Extreme 174.85
214.80
Current year
174.85
Extreme 174.85
240.20
1 year
174.85
Extreme 174.85
240.20
3 years
174.20
Extreme 174.2
431.60
5 years
127.30
Extreme 127.3
431.60
10 years
74.74
Extreme 74.74
431.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 01/17/01
Director of Finance/CFO - 15/22/15
Chairman 63 01/97/01
Members of the board TitleAgeSince
Director/Board Member 68 01/07/01
Director/Board Member 73 01/89/01
Chairman 63 01/97/01
More insiders
Date Price Change Volume
18/24/18 214 +14.26% 2 257 100
17/24/17 187.3 +1.05% 737,178
16/24/16 185.4 -0.19% 527,550
15/24/15 185.7 -2.98% 581,150
12/24/12 191.4 +1.48% 663,019

Delayed Quote Nasdaq Stockholm, July 18, 2024 at 04:46 pm IST

More quotes
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (29.4%); - contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications. Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%). At the end of 2021, the group had 20 production sites worldwide. Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
187.3 SEK
Average target price
224.9 SEK
Spread / Average Target
+20.06%
Consensus
  1. Stock Market
  2. Equities
  3. GETI B Stock